Imaging: Why It Looks Suspicious and What MRI Does

For many patients, the path to a cystadenofibroma diagnosis begins with an alarming ultrasound report. Because this tumor contains both fluid-filled sacs and solid fibrous tissue, it often looks “complex” or “suspicious” on initial scans ^[1][2]. Understanding how imaging works—and why it can be misleading—is key to managing the anxiety that often follows these first tests.

Why Ultrasound is Often Alarming

Ultrasound is typically the first tool used to look at an ovarian mass. In many cases, it flags features that are traditionally associated with cancer or borderline tumors (low-malignancy-potential growths) ^[3]. In studies of patients diagnosed with serous cystadenofibromas, imaging frequently showed:

• Solid Components: Many of these tumors contain solid areas that look highly cellular on an ultrasound ^[4].
• Papillary Projections: These are finger-like growths inside a cyst. Because they are common in ovarian cancer, they often trigger a “suspicious” rating ^[4][3].
• Multilocular Cysts: The tumor may have multiple “rooms” or internal walls (septa), which adds to its complex appearance ^[2].

In a cystadenofibroma, these solid-looking areas are actually just dense fibrous tissue (the stroma). However, on an ultrasound, this benign tissue mimics the appearance of aggressive cell growth ^[1].

The MRI “Tiebreaker”

If an ultrasound is inconclusive, your doctor may order a pelvic MRI to improve the risk assessment. MRI is better at identifying dense fibrous tissue ^[2].

Radiologists sometimes look for a specific clue known as the dark-dark pattern:

1. Low T2 Signal: On a specific MRI setting (T2-weighted imaging), the solid part of the tumor looks very dark. This suggests the tissue is dense and fibrous, rather than cellular ^[2][1].
2. No Diffusion Restriction: Cancer cells are usually packed tightly together, which “restricts” the movement of water molecules. In a cystadenofibroma, water moves more freely. When a tumor is dark on T2 imaging and shows no diffusion restriction, it is a strong hint that the mass is a benign cystadenofibroma rather than cancer ^[2].

Why Imaging Can’t Give the Final Answer

While MRI is helpful and can lower the suspected risk of cancer, it cannot provide a 100% certain diagnosis. Imaging can only suggest what a tumor might be based on its signals ^[1].

• Overlap: Some rare cancers or borderline tumors can occasionally share imaging features with a cystadenofibroma, and fibrous tissue does not always behave perfectly on scans ^[2].
• Sampling Limits: A tumor might be benign in one area but have more concerning cells in another. A scan looks at the whole mass, but it can’t see microscopic individual cells ^[5][6].

Because of this, a definitive diagnosis always requires histopathology—examining the actual tissue under a microscope ^[5][7].

Managing “Indeterminate” Results

If your imaging report uses words like “indeterminate,” “complex,” or “cannot exclude malignancy,” it simply means the imaging has reached the limit of what it can tell the care team ^[1]. Depending on your risk factors, the mass’s size, and your symptoms, management might include watchful waiting (monitoring with repeat scans) or surgical removal. Surgery is often recommended not because a doctor is sure the mass is cancer, but to resolve symptoms, prevent torsion, and get a definitive tissue answer ^[7][8].